AI assistant
Sending…
AEHR TEST SYSTEMS — Director's Dealing 2023
Feb 2, 2023
32300_dirs_2023-02-02_eca1ce98-e620-4bf0-a4ba-b5bab19f9aba.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AEHR TEST SYSTEMS (AEHR)
CIK: 0001040470
Period of Report: 2023-01-31
Reporting Person: Erickson Gayn (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-01-31 | Common Stock | M | 23856 | $3.9300 | Acquired | 519109 | Direct |
| 2023-01-31 | Common Stock | M | 80997 | $2.4000 | Acquired | 600106 | Direct |
| 2023-01-31 | Common Stock | M | 18958 | $1.6350 | Acquired | 619064 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2023-01-31 | Incentive Stock Option (right to buy) | $1.6350 | M | 18958 | Disposed | 2026-07-16 | Common Stock (18958) | Direct |
| 2023-01-31 | Incentive Stock Option (right to buy) | $2.4000 | M | 80997 | Disposed | 2025-08-17 | Common Stock (80997) | Direct |
| 2023-01-31 | Incentive Stock Option (right to buy) | $3.9300 | M | 23856 | Disposed | 2024-07-11 | Common Stock (23856) | Direct |
Footnotes
F1: The amount reported includes shares subject to unvested restricted stock units and unvested restricted shares.
F2: One forty-eighth (1/48) of the total number of shares became exercisable on this date and an additional one forty-eighth (1/48) of the total number of shares became exercisable each month thereafter.
More from AEHR TEST SYSTEMS
Regulatory Filings
2026
Apr 20
Regulatory Filings
2026
Apr 8
Regulatory Filings
2026
Apr 7
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 13
Director's Dealing
2026
Feb 10
Regulatory Filings
2026
Feb 9
Major Shareholding Notification
2026
Feb 9
Director's Dealing
2026
Feb 4